ALFA FinderBSE filing, NSE: DRREDDY. Summary written from the filing by ALFA Finder's alert engine.
Dr. Reddy's Laboratories Ltd: key numbers
- Share price
- ₹1,377.00
- Market cap
- ₹1,14,935 Cr
- Revenue (annual)
- ₹33,700 Cr
- Net profit (annual)
- ₹4,196 Cr
- P/E (TTM)
- 41.0×Sector 43.4×
- Promoter holding
- 26.63%-0.01% QoQ
- FII holding
- 20.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Reddy's Laboratories Ltd
All →Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Dr. Reddy's Laboratories Other Announcement
Dr Reddy's KMP Erez Israeli sold 460,276 ADRs to cover the exercise of 591,270 ADRs allotted under ESOP. The disposal is valued at about ₹61.76 Crore.
- Value
- ₹61.76 Cr
Dr. Reddy's Laboratories Employee Stock Options
Dr. Reddy's allotted 5,91,270 equity shares to employees on exercise of stock options under its ADR ESOP Scheme 2007. Exercise prices ranged from Re.1 to Rs.1,060.20 per share.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Dr. Reddy's Laboratories Earnings Call Transcript: Key Takeaways
Revenue declined 1.5% YoY as lower Revlimid sales in North America offset strong double-digit growth in base business and emerging markets.
- Call
- Guides 25% growth
Other board meeting date announcements
All →Avio Smart Market Stack Board Meeting Date
Avio Smart Market Stack's board meets November 14, 2026 to approve Q2 and H1 results. Trading window stays closed amid an ongoing rights issue.
Rajnandini Fashion India Board Meeting Date
Rajnandini Fashion India will hold a board meeting on 14 November 2026 to consider unaudited standalone results for the half year ended 30 September 2026. The trading window remains closed until 48 hours after the results.
Himatsingka Seide Board Meeting Date
Himatsingka Seide gave prior notice of a board meeting on 14 November 2026 to approve Q2 and H1 FY27 results. The trading window stays closed until 48 hours after the results are declared.
Neetu Yoshi Board Meeting Date
Neetu Yoshi Ltd has scheduled a board meeting on 14 November 2026 to consider its half-year unaudited financial results. The trading window stays closed until 48 hours after the results are communicated.
Tejas Cargo India Board Meeting Date
Tejas Cargo India will meet on 14 November 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 16 November 2026.
Mansi Finance (Chennai) Board Meeting Date
Mansi Finance (Chennai) will hold a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter ended September 2026. The trading window stays closed until 16 November 2026.